Cas:779999-14-3 N-pyridin-3-ylpiperidine-4-carboxamide manufacturer & supplier

We serve Chemical Name:N-pyridin-3-ylpiperidine-4-carboxamide CAS:779999-14-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-pyridin-3-ylpiperidine-4-carboxamide

Chemical Name:N-pyridin-3-ylpiperidine-4-carboxamide
CAS.NO:779999-14-3
Synonyms:N-pyridin-3-ylpiperidine-4-carboxamide
Molecular Formula:C11H15N3O
Molecular Weight:205.25600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:427.126ºC at 760 mmHg
Density:1.178 g/cm3
Index of Refraction:
PSA:54.02000
Exact Mass:205.12200
LogP:1.42150

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-pyridin-3-ylpiperidine-4-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-pyridin-3-ylpiperidine-4-carboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-pyridin-3-ylpiperidine-4-carboxamide Use and application,N-pyridin-3-ylpiperidine-4-carboxamide technical grade,usp/ep/jp grade.


Related News: Johnson & Johnson’s COVID-19 vaccine presents greater benefits than it does safety risks, especially amid the quickly spreading Delta variant, a key CDC expert panel decided. However, the panel said that a ruling over the need for a booster added to all COVID shots will have to start with the FDA. Di-(3-acetoxy-propyl)-butyl-phosphinsulfid manufacturers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. N[2-oxo-2-(N-((2-methyl-2-thio)propyl)amino)ethyl]2-(methylthio)aniline suppliers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, 2-(Aminomethylen)-2-(phenylacetamido)-p-methoxy-acetanilid vendor & factory Ireland is globally recognised as a hub for the Life Sciences sector and this news is a real vote of confidence in us and our capacity.”,Its approval has since been called into question, however, and the head of the FDA is now calling for a federal investigation looking into interactions between agency staff and the biotech company.